Hospitals like Boston Children's and Penn Medicine think they are better off building in-house apps that are custom-made for their workflow, rather than risk buying those available in the market, which may not necessarily be a perfect fit.
Subha Airan-Javia, MD, and Stephanie Altavilla, RN, faced the same set of choices when they set out to create apps for their hospitals.
The first was whether to buy an existing app on the open market and try to fit it into their infrastructure, knowing that there was no guarantee it would fit smoothly into the existing workflows and that they might be faced with users who were unwilling to adopt it.
Or, they could write the apps internally.
The build versus buy decision can be a difficult one. Despite the hailstorm of apps available for free or at a relatively low cost, many of those geared toward hospitals or providers can be tricky to plug into existing workflows, let alone customize. Building an app with internal resources requires careful planning and a need to manage a development process. But providers like Boston Children's and Penn Medicine are rising to the challenge, creating their own apps with exactly the features and functionality their staff needs.
Link to the complete article on Healthcare IT News:
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Emily Goldberg Shares Insights as a Genetic Counselor for Breast Cancer Risk Screening
October 30th 2023On this episode of Managed Care Cast, Emily Goldberg, MS, CGC, a genetic counselor at JScreen, breaks down how genetic screening for breast cancer works and why it is so important to increase awareness and education around these screening tools available to patients who may be at risk for cancer.
Listen
Machine Learning Model Predicts Hepatocellular Carcinoma Risk in Patients With MASLD
March 22nd 2024Machine learning models have potential for early identification of patients with metabolic dysfunction-associated steatotic liver disease (MASLD) who are at risk of hepatocellular carcinoma.
Read More